Information  X 
Enter a valid email address

OXFORD NANO (ONT)

Date Time Source Announcement
01 Aug 2022 5:30 pm
RNS
Issue of Equity and Total Voting Rights
12 Jul 2022 5:00 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
11 Jul 2022 7:00 am
RNS
Sale and leaseback of headquarters building
01 Jul 2022 5:16 pm
RNS
Issue of Equity and Total Voting Rights
30 Jun 2022 7:15 am
RNS
Duncan Tatton-Brown appointed as Non-Exec Chair
23 Jun 2022 4:30 pm
RNS
Result of AGM
13 Jun 2022 4:00 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Jun 2022 4:00 pm
RNS
Issue of Equity and Total Voting Rights
31 May 2022 6:30 pm
RNS
Director/PDMR Shareholding
26 May 2022 7:00 am
RNS
ONT releases Remora:most comprehensive methylation
20 May 2022 7:00 am
RNS
Oxford Nanopore announces tech updates
19 May 2022 9:06 am
RNS
ONT opens user conference, rich science programme
13 May 2022 7:00 am
RNS
ONT chosen for comprehensive human genome program
11 May 2022 4:00 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
03 May 2022 4:00 pm
RNS
Issue of Equity and Total Voting Rights
12 Apr 2022 6:15 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
  1:01 pm
RNS
Director/PDMR Shareholding
  1:01 pm
RNS
Director/PDMR Shareholding
  1:00 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Publication of Annual Report and Notice of AGM
06 Apr 2022 1:00 pm
RNS
Block listing Interim Review
05 Apr 2022 11:00 am
RNS
Director/PDMR Shareholding
04 Apr 2022 2:00 pm
RNS
Genomics England expands Nanopore use in cancer
01 Apr 2022 5:00 pm
RNS
Issue of Equity and Total Voting Rights
  7:00 am
RNS
Agreement
30 Mar 2022 2:00 pm
RNS
ONT shows new high-accuracy, high-output chemistry
24 Mar 2022 7:00 am
RNS
Nanopore sequencing profiles TB: FIND evaluation
23 Mar 2022 2:02 pm
RNS
Oxford Nanopore releases Short Fragment Mode
22 Mar 2022 7:00 am
RNS
Preliminary Results and Guidance Update
11 Mar 2022 5:00 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
10 Mar 2022 12:30 pm
RNS
Holding(s) in Company
08 Mar 2022 7:03 am
RNS
Publication: Nanopore IDs >50 genetic diseases
01 Mar 2022 5:00 pm
RNS
Issue of Equity and Total Voting Rights
24 Feb 2022 7:00 am
RNS
Notice of Results
11 Feb 2022 5:30 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Feb 2022 5:00 pm
RNS
Issue of Equity and Total Voting Rights
24 Jan 2022 3:00 pm
RNS
Appointment of Senior Independent Director
18 Jan 2022 1:00 pm
RNS
Holding(s) in Company
13 Jan 2022 7:00 am
RNS
Fastest human genome sequence uses Oxford Nanopore
11 Jan 2022 6:00 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
07 Jan 2022 12:00 pm
RNS
Update to FY21 revenue guidance
  7:00 am
RNS
Company to present at JP Morgan Healthcare conf
04 Jan 2022 6:30 pm
RNS
Issue of Equity and Total Voting Rights
20 Dec 2021 5:00 pm
RNS
Holding(s) in Company
13 Dec 2021 6:15 pm
RNS
Share Incentive Plan - Director/PDMR Shareholding
02 Dec 2021 7:00 am
RNS
Oxford Nanopore announces technology updates
01 Dec 2021 7:00 am
RNS
Issue of Equity and Total Voting Rights
09 Nov 2021 7:03 am
RNS
Update to revenue guidance
03 Nov 2021 6:00 pm
RNS
Holding(s) in Company
01 Nov 2021 6:30 pm
RNS
PDMR Notification (ESPP) and Director Declaration
  7:00 am
RNS
Issue of Equity and Total Voting Rights
14 Oct 2021 5:33 pm
RNS
Upgrade to full-year revenue guidance
13 Oct 2021 6:20 pm
RNS
Share Incentive Plan, Director/PDMR Transactions
08 Oct 2021 12:00 pm
RNS
Exercise of Over-allotment Option
  7:00 am
RNS
Notification of Transactions of Director/PDMR
  7:00 am
RNS
Total Voting Rights
07 Oct 2021 6:00 pm
RNS
Holding(s) in Company

a d v e r t i s e m e n t